Hans-W. Klafki

Electrophoretic Separation of βA4 Peptides (1–40) and (1–42)

Hans-W. Klafki, Jens Wiltfang, Matthias Staufenbiel · Analytical Biochemistry · 1996 · 99 citations

Biochemistry, Peptide Library, Bioanalysis +5

A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease

Hedieh Shahpasand‐Kroner, Hans-W. Klafki, Chris Bauer et al. · Alzheimer s Research & Therapy · 2018 · 65 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Biomarkers +8

Calpain inhibitor I decreases βA4 secretion from human embryonal kidney cells expressing β-amyloid precursor protein carrying the APP670/671 double mutation

Hans-W. Klafki, Paolo Paganetti, Bernd Sommer et al. · Neuroscience Letters · 1995 · 34 citations

Calpain Inhibitor, Developmental Biology, β-Amyloid Precursor Protein +4

Reproducibility of Alzheimer’s Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions

Jonathan Vogelgsang, Dirk Wedekind, Caroline Bouter et al. · Journal of Alzheimer s Disease · 2018 · 21 citations · Full text

Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort

Hans-W. Klafki, Henning Hafermann, Chris Bauer et al. · Journal of Alzheimer s Disease · 2016 · 14 citations · Full text